Healthcare News and Research

Latest Healthcare News and Research

Boston Scientific and CryoCor collaborate in atrial fibrillation

CryoCor, Inc. and Boston Scientific Corporation have announced a strategic collaboration in the field of cryoablation, or the use of extreme cold, for the treatment of cardiac arrhythmias.

29 Jun 2007

Biovest announces interim blinded data of fast-tracked pivotal phase 3 clinical trial of BiovaxID

Biovest International announced on June 27, 2007 blinded interim data from the start of its fast-tracked pivotal Phase 3 clinical trial of BiovaxID for Non-Hodgkin's lymphoma (NHL) from September 2000 through June 2006.

29 Jun 2007

One in 10 hospice patients are referred too late for services

The study is based on surveys completed by bereaved family members and designed to gauge the quality of hospice programs, which provide medical care with social, emotional and spiritual support for the dying.

29 Jun 2007

Summer's here so look out for Legionnaires disease

Summer's here and the living isn't always so easy especially if youre in the hospital. Patients who are vulnerable to infection run a greater risk of contracting Legionnaires disease, a severe form of pneumonia, during warm, humid weather, according to a study published in the Journal of Infectious Diseases.

28 Jun 2007

CDC website tracks infections

A secure, Web-based reporting network that lets facilities track infections associated with health care is now available to all health care facilities in the United States, the Centers for Disease Control and Prevention (CDC) has announced.

28 Jun 2007

Bayer and Onyx submit supplemental NDA for Nexavar

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that a Supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar is currently approved in more than 50 countries for the treatment of advanced kidney cancer.

28 Jun 2007

Training autistic brains to recognize visual and vocal cues

To understand the meaning of a conversation, kids automatically do what adults do - besides processing the meaning of words, they unconsciously "read" the expression on a person's face and listen to their tone of voice, then integrate that information with the context at hand to discern meaning, be it humor, anger, irony or straightforwardness.

28 Jun 2007

University of Cincinnati researchers create new system to reduce medical errors

Defining what constitutes quality care especially in a large, urban hospital isn't easy.

27 Jun 2007

Doctors need to shut up and listen!

Doctors it seems often waste time talking about their own problems in a well-intentioned effort to establish a patient relationship, rather than find out what is actually wrong with their patient.

26 Jun 2007

Threat of MRSA superbug under-estimated

According to the Center for Disease Control in the United States (CDC), MRSA (Methicillin-Associated Staphylococcus Aureus) infections continue to be a concern for hospitals worldwide and now account for more than 50% of hospital-acquired Staphylococcus aureus infections.

26 Jun 2007

Roche makes offer to acquire Ventana Medical Systems

Roche will make a tender offer to acquire all outstanding shares of common stock of Ventana Medical Systems for $75.00 per share in cash, or an aggregate of approximately $3 billion on a fully diluted basis.

From Roche Sequencing and Life Science 26 Jun 2007

Conference to address healthcare policy and patient safety

Practical solutions for boosting quality in healthcare and patient safety will take center stage when the American Academy of Otolaryngology – Head and Neck Surgery hosts the 2007 Quality in Otolaryngology conference in Arlington, VA.

26 Jun 2007

Personal comments by physicians distract from patient needs

In well-intentioned efforts to establish relationships, some physicians tell patients about their own family members, health problems, travel experiences and political beliefs.

26 Jun 2007

Patients with an alcohol-use disorder are more likely to require mechanical ventilation

More than 300,000 patients receive mechanical ventilation during intensive care per year in the United States, even though the hospital mortality rate for ventilated patients can approach 50 percent.

26 Jun 2007

Ranbaxy receives tentative FDA approval for Tamsulosin capsules

Ranbaxy Pharmaceuticals has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Tamsulosin Hydrochloride Capsules, 0.4 mg.

23 Jun 2007

Medical error is the fifth-leading cause of death in the U.S.

Millennium Research Group (MRG) has conducted a detailed and thorough analysis of the acute care clinical information systems (CIS) market and finds that a major driver in the US is the demand for improvement in patient safety.

23 Jun 2007

Pulmonary function testing in children aged 2 to 6

The ATS and European Respiratory Society (ERS) published a new statement on pulmonary function testing in preschool children.

23 Jun 2007

Report on MRSA to show superbug is widespread in hospitals

The Association for Professionals in Infection Control and Epidemiology (APIC) will release the results of the first nationwide study on the prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) in U.S. healthcare facilities.

23 Jun 2007

Arpida receives FDA approval to initiate Phase II trial with intravenous iclaprim

Arpida Ltd. has announced that it has received approval from the US Food and Drug Administration for a Phase II trial with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare-associated pneumonia (HCAP) suspected or confirmed to be due to Gram-positive pathogens.

23 Jun 2007

Genzyme files for FDA approval of single-treatment Synvisc-One

Genzyme Corp. has announced that it has filed with the U.S. Food and Drug Administration (FDA) for approval of Synvisc-One, the single treatment of Synvisc (hylan G-F 20) that provides up to six months of pain relief from osteoarthritis (OA) of the knee.

23 Jun 2007